Cargando…

Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives

This paper describes an LC-MS/MS method to determine the concentration of spironolactone and its metabolites 7-alpha-methylthiospironolactone and canrenone in blood plasma samples. The resulting assay is simple (using protein precipitation for sample preparation) and sensitive (the lower limit of qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Takkis, Kalev, Aro, Rudolf, Kõrgvee, Lenne-Triin, Varendi, Heili, Lass, Jana, Herodes, Koit, Kipper, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395588/
https://www.ncbi.nlm.nih.gov/pubmed/28224249
http://dx.doi.org/10.1007/s00216-017-0255-4
_version_ 1783229893550538752
author Takkis, Kalev
Aro, Rudolf
Kõrgvee, Lenne-Triin
Varendi, Heili
Lass, Jana
Herodes, Koit
Kipper, Karin
author_facet Takkis, Kalev
Aro, Rudolf
Kõrgvee, Lenne-Triin
Varendi, Heili
Lass, Jana
Herodes, Koit
Kipper, Karin
author_sort Takkis, Kalev
collection PubMed
description This paper describes an LC-MS/MS method to determine the concentration of spironolactone and its metabolites 7-alpha-methylthiospironolactone and canrenone in blood plasma samples. The resulting assay is simple (using protein precipitation for sample preparation) and sensitive (the lower limit of quantification is close to 0.5 ng/ml) while requiring only 50 μl of plasma, making it especially suitable for analyzing samples obtained from pediatric and neonatal patients where sample sizes are limited. The sensitivity is achieved by using ammonium fluoride as an eluent additive, which in our case amplifies the signal from our analytes in the plasma solution on average about 70 times. The method is fully validated according to the European Medicines Agency’s guideline and used for the measurement of pediatric patients’ samples in clinical trials for evaluating oral spironolactone’s and its metabolites’ pharmacokinetics in children up to 2 years of age.
format Online
Article
Text
id pubmed-5395588
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-53955882017-05-04 Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives Takkis, Kalev Aro, Rudolf Kõrgvee, Lenne-Triin Varendi, Heili Lass, Jana Herodes, Koit Kipper, Karin Anal Bioanal Chem Research Paper This paper describes an LC-MS/MS method to determine the concentration of spironolactone and its metabolites 7-alpha-methylthiospironolactone and canrenone in blood plasma samples. The resulting assay is simple (using protein precipitation for sample preparation) and sensitive (the lower limit of quantification is close to 0.5 ng/ml) while requiring only 50 μl of plasma, making it especially suitable for analyzing samples obtained from pediatric and neonatal patients where sample sizes are limited. The sensitivity is achieved by using ammonium fluoride as an eluent additive, which in our case amplifies the signal from our analytes in the plasma solution on average about 70 times. The method is fully validated according to the European Medicines Agency’s guideline and used for the measurement of pediatric patients’ samples in clinical trials for evaluating oral spironolactone’s and its metabolites’ pharmacokinetics in children up to 2 years of age. Springer Berlin Heidelberg 2017-02-21 2017 /pmc/articles/PMC5395588/ /pubmed/28224249 http://dx.doi.org/10.1007/s00216-017-0255-4 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research Paper
Takkis, Kalev
Aro, Rudolf
Kõrgvee, Lenne-Triin
Varendi, Heili
Lass, Jana
Herodes, Koit
Kipper, Karin
Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives
title Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives
title_full Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives
title_fullStr Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives
title_full_unstemmed Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives
title_short Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH(4)F as eluent additives
title_sort signal enhancement in the hplc-esi-ms/ms analysis of spironolactone and its metabolites using hfip and nh(4)f as eluent additives
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395588/
https://www.ncbi.nlm.nih.gov/pubmed/28224249
http://dx.doi.org/10.1007/s00216-017-0255-4
work_keys_str_mv AT takkiskalev signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives
AT arorudolf signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives
AT korgveelennetriin signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives
AT varendiheili signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives
AT lassjana signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives
AT herodeskoit signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives
AT kipperkarin signalenhancementinthehplcesimsmsanalysisofspironolactoneanditsmetabolitesusinghfipandnh4faseluentadditives